Immatics (IMTX) Total Current Liabilities (2019 - 2025)

Immatics (IMTX) posted Total Current Liabilities of $50.1 million for Q4 2025, down 31.21% sequentially from $72.8 million in Q3 2025, and down 31.08% YoY from $72.7 million in Q4 2024.

Immatics (IMTX) Total Current Liabilities (2019 - 2025) Analysis & Trends

Immatics has reported Total Current Liabilities for 7 years, with the latest figure at $50.1 million in Q4 2025.

  • Quarterly Total Current Liabilities fell 31.08% year-over-year to $50.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $50.1 million (down 31.08% YoY) and the FY2025 annual result came in at $48.6 million, down 33.96% from the prior year.
  • Total Current Liabilities eased to $50.1 million in Q4 2025 per IMTX's latest filing, from $72.8 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $168.4 million in Q4 2023 and troughed at $50.1 million in Q4 2025.
  • A 5-year average of $111.9 million and a median of $111.0 million in 2021 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2023 and 2025: Total Current Liabilities surged 55.09% in 2023, then tumbled 63.78% in 2025.
  • Over 5 years, Total Current Liabilities stood at $108.8 million in 2021, then fell by 0.22% to $108.6 million in 2022, then soared by 55.09% to $168.4 million in 2023, then plunged by 56.87% to $72.7 million in 2024, then tumbled by 31.08% to $50.1 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $50.1 million, $72.8 million, and $64.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 1.58 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 354.06 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 2.12 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 4.22 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 630.93 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.51 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 438.74 Mn
10 Immatics 1.27 Bn 719.31 Mn - 50.07 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 50.07 Mn
Sep 30, 2025 72.78 Mn
Jun 30, 2025 64.80 Mn
Mar 31, 2025 58.66 Mn
Dec 31, 2024 72.65 Mn
Sep 30, 2024 141.57 Mn
Jun 30, 2024 161.04 Mn
Mar 31, 2024 161.98 Mn
Dec 31, 2023 168.44 Mn
Sep 30, 2023 131.88 Mn
Jun 30, 2023 135.36 Mn
Mar 31, 2023 107.96 Mn
Dec 31, 2022 108.61 Mn
Sep 30, 2022 125.15 Mn
Jun 30, 2022 121.64 Mn
Mar 31, 2022 103.09 Mn
Dec 31, 2021 108.85 Mn
Sep 30, 2021 126.33 Mn
Jun 30, 2021 113.12 Mn
Mar 31, 2021 103.84 Mn